Nanobiotix SA
NBTX
View Detailed Chart
20.850USD
-0.180-0.86%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
1.01BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.86%
5 Days
-0.71%
1 Month
+2.36%
6 Months
+202.17%
Year to Date
-9.82%
1 Year
+492.33%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Nanobiotix SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nanobiotix SA Info
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Ticker SymbolNBTX
CompanyNanobiotix SA
CEOLevy (Laurent)
Websitehttps://www.nanobiotix.com
Related Instruments
+3.66%
+3.17%
+0.93%
+1.99%
+1.78%
+1.60%
-0.95%
+4.49%
+2.10%
+10.00%
+2.72%
+4.15%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69072.880
-897.250 (-1.28%)
282.580
+22.390 (+8.61%)
2040.550
-11.180 (-0.55%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
